Transgenic overexpression of the pituitary stem cell marker PROP1 under control of the αGSU promoter also leads (after 1 year) to pituitary tumors including non-hormonal, GH-, PRL-, GH/PRL-, PRL/αGSU-, and TSH-producing adenomas (38, 39). Here, PROP1 is linked to pituitary tumor.